In this study, a magnetic nanomaterial was used for the binding of anionic arsenic species from contaminated groundwater. Iron oxide (Fe3O4) magnetic nanoparticles (NPs) and the surface modified Fe3O4 NPs with 3-aminopropyl-triethoxysilane (3-APTES), Trisodium citrare (TSC) and Chitosan were synthesized with the co-precipitation method. Structural characterizations showed that the four kinds of NPs had different sizes an average particle range size of 15-20 nm was observed with Transmission Electron Microscopy. X-ray diffraction was used to identify the crystalline structure of synthesized Fe3O4 and surface modified NPs. Molecular structure and functional groups present in synthesized magnetic NPs Fe3O4 were identify with infrared analysis. The synthesized Fe3O4 NPs and surface coated NPs were used for determine the binding capacity of Arsenic ions from the synthetic groundwater. The binding of As(III) increased as the dissolved As(III) concentration increased in the solution. From the experiments it was found chitosan-coated NPs are best than other coated and uncoated NPs for arsenite removal from the solution. It was found that if only As(III) ions were present in the water without other anions and cations the binding capacity of the magnetic NPs is very high. The binding capacity of As ions was decreased with presence of other anions and cations in the groundwater because they interfere with arsenic binding sites which presence on the magnetic NPs.

Superparamagnetic -Fe2O3 nanoparticles were synthesized by coprecipitation of ferric and ferrous salts with a base. Resulting nanoparticles were coated with shells, such as poly(N,N- dimethylacrylamide) (PDMAAm), neat and functionalized silica (SiO2 and SiO2-NH2), and polyaniline (PANI). PDMAAm shell was introduced by modification of iron oxide nanoparticle surface with an initiator and N,N-dimethylacrylamide was polymerized producing -Fe2O3&PDMAAm core-shell particles. In case of SiO2-NH2 shell, tetramethyl orthosilicate was used to yield -Fe2O3&SiO2 nanoparticles, which were subsequently modified by (3-aminopropyl)triethoxysilane to prepare γ-Fe2O3&SiO2-NH2 particles. Oxidation of aniline hydrochloride with ammonium persulfate in an aqueous solution of poly(N-vinylpyrrolidone) in the presence of iron oxides produced -Fe2O3&PANI nanoparticles. Finally, the last type of the particles was based on thionin-modified poly(carboxymethyl methacrylate) (PCMMA&Th). The particles were characterized by techniques, such as scanning and transmission electron microscopy (SEM and TEM) and dynamic light scattering (DLS) to determine the particle morphology and hydrodynamic diameter. The presence of the functional groups, chemical composition, and the iron content were investigated by Fourier-transform...

In this thesis the influence of deposition conditions and post-deposition annealing on the structure of ultrathin iron oxide films grown on magnesium oxide (MgO) substrates is studied. The main experimental technique used is synchrotron based x-ray diffraction (XRD) but also x-ray photoelectron spectroscopy (XPS) and low energy electron diffractions (LEED) are used to characterize the samples. Studying the dependency of film structure and thickness the stoichiometry and structure is changing with increasing film thickness. For large film thickness bulk like magnetite (Fe3O4) can be observed. With decreasing thickness the oxide phase is shifting towards a wüstite (FeO) phase. When changing the deposition rate and substrate temperature a strong influence on the Fe3O4 film structure is observed. With both decreasing deposition rates and substrate temperatures the occupancy of the tetrahedral sites is strongly decreasing while the octahedral sites remain almost unaffected. By post-deposition annealing under low oxygen atmosphere it is possible to increase the ordering of the tetrahedral sites. However, this is accompanied by significant diffusion of magnesium into the iron oxide film. During post-deposition annealing of a gamma-Fe2O3 film under high vacuum a reduction of the iron oxide is observed. Increasing the temperature, first, a reduction from gamma-Fe2O3 to Fe3O4 is observed. After further increasing the temperature a reduction from Fe3O4 to FeO is observed.

京都大学 / 0048 / 新制・課程博士 / 博士(工学) / 甲第19189号 / 工博第4066号 / 新制||工||1627(附属図書館) / 32181 / 京都大学大学院工学研究科合成・生物化学専攻 / (主査)教授 北川 進, 教授 濵地 格, 教授 森 泰生 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DGAM

Steel corrosion is one of the major distress mechanisms that causes the deterioration of reinforced concrete structures around the world. It is an electrochemical reaction between the reinforcing steel and the surrounding concrete that produces a mass loss of the metal. Through the process of corrosion in reinforced concrete, iron ions get oxidized to form corrosion products (CP). Although multiple experiments and studies have been developed to understand the rheological behavior of corrosion products, this topic stays inconclusive. This work aims to characterize corrosion products at micro-scale in order to trace the progress of the formation of rust, to determine its nature and to analyse its rheological behavior in reinforced concrete. An experimental procedure to produce CP in the laboratory is also presented in this research. In addition, material characterization methods have been used to identify the iron oxide phases present in CP, determine their viscosity and rheological behavior and to study how CP flows in a porous media. In order to identify the different stages in the corrosion process, the CP was analysed at 2, 4, 6 and 8 weeks. The experiments identified four phases of iron oxide for each period. Furthermore, it was found that CP behaves as a shear-thinning slurry and as a result, its viscosity decreases with the applied shear rate. In addition, the damage caused by CP on concrete depends on the w/c ratio of the concrete mix and the exposure time to a corroding environment. The rebar mass loss results show that CP is formed in layers around the rebar, and the flow of each CP layer can differ.

No description available.

<p> Aqueous ferrofluid has been prepared via precipitation of iron oxide into a polysaccharide gel matrix followed by degradation of the polymer to form a stable magnetic colloid. Nanocrystalline particles of iron oxide were formed in an alginate network by the alkaline hydrolysis and oxidation of the crosslinking agent, Fe2+, used to bind the linear polysaccharide chains. Methanol was used to inhibit the degradation of alginate by Fe2+ and oxygen during the precipitation and growth of iron oxide particles. In addition, the structural integrity of the gel was maintained in part by interaction between the iron oxide particulate and the alginate matrix. Controlled chemical degradation of the matrix resulted in a aqueous suspension of alginate-stabilized magnetic iron oxide particles. The resulting fluid is orange-brown in color, optically transparent, superparamagnetic and stable between 2.8<pH<10 </p> <p> The magnetic gels were isolated as 2mm beads containing ~2-20 mmole Fe. X-ray and electron diffraction patterns of the composite correspond to maghemite (γ-Fe2O3) and/or magnetite (Fe3O4). At room temperature, the composite material is superparamagnetic with saturation magnetizations in excess of 20 emu g^-1 at 30kOe. TEM photomicrographs of sectioned beads and of the magnetic fluid revealed the presence of spherical nanocrystalline oxide particles with diameters ranging from 3 nm to 6 nm. The iron oxide-alginate colloid has a diameter of 54nm with an average zeta potential of -51.6 mV.</p> / Thesis / Master of Science (MSc)

The capability of precisely controlling the kinetics of therapeutic delivery at the optimal location and rate for a given patient would have great potential to improve health and well-being in a range of current drug therapies (insulin, chemotherapeutics, vaccines, etc.). Indeed, if successfully developed, locally administered injectable drug delivery vehicles capable of remotely-triggered release would be the gold standard for many treatments. Multiple injectable nanocomposites have been investigated for this purpose that are generally comprised of a thermosensitive polymeric material and superparamagnetic iron oxide nanoparticles (SPIONs). SPIONs generate heat when exposed remote alternating magnetic fields (AMFs), and the transfer of this heat to thermosensitive polymers can be used to control the release of therapeutics. Ideally, these systems would be capable of returning to their original state and basal release rate when the external AMF trigger is removed. Several novel injectable nanocomposite materials that explore interactions between SPIONs and thermosensitive polymers to mediate drug release, from the macroscale to the nanoscale, were developed and demonstrated to be capable of remotely-triggered, AMF-mediated enhanced release. The macroscale magnetic nanocomposites have thermosensitive hydrogel and/or microgel components that regulate release based on the heat produced from SPIONs in response to an external AMF. On the millimeter-scale, a microinjection system capable of producing thermosensitive hydrogel beads that could potentially incorporate SPIONs is described. On the nanoscale, nanoparticles with a glass transition temperature and thermosensitive microgels are combined with SPIONs and investigated for their remote, AMF-mediated release characteristics. The engineered macroscale and nanoscale systems are capable of up to ~4:1 and ~7:1 enhancements in release due to an AMF application, respectively, compared to the basal release rate. Collectively, these nanocomposites represent a promising stride towards improved remote-actuation of drug release and a stepping stone for future attempts at precisely controlling the site and kinetics of drug release. / Thesis / Doctor of Philosophy (PhD) / This thesis focuses on the development of nanocomposite materials that can be injected into a specific location in the body and deliver therapeutic drugs by a remote-controlled process. These nanocomposites are composed of magnetic particles and polymers that respond to changes in temperature. The combination of these materials results in nanocomposites that can change their properties in response to specific magnetic fields to switch from releasing drug slowly (or not at all) to releasing drug quickly on demand. The changes are fully reversible and solely depend on whether the external magnetic field is switched on or off. These novel systems offer an alternative to therapies that require frequent injections, such as insulin for diabetes, or therapies that need the drug to be released in very precise locations, such as cancer treatments, and could improve the safety, reduce the risk of side effects, and lower the cost of many medical treatments.

No description available.

The Leveäniemi iron oxide apatite (IOA) deposit, mined by LKAB, is located in Norrbotten, northern Sweden. The deposit has a partially more complex mineralogy than the neighbouring and more famous IOA deposits of Kiirunavaara and Malmberget. The Leveäniemi deposit contains comparatively more ore containing both magnetite and hematite but also maghemite and with slightly different trace element chemistry of the iron oxide minerals. Hematite is currently not considered a valuable mineral in the Svappavaara mineral processing and in the magnetite concentrate titanium and vanadium are considered to be penalty elements. Ore samples were collected from selected drill cores and from these polished thin sections were prepared that were investigated by optical microscopy, EPMA, and FE-SEM-EDS. Investigations focused on iron oxide mineralogy and mineral chemistry with special consideration to titanium and vanadium as those elements are considered deleterious in subsequent blast furnace or direct reduction processes. Investigations revealed that magnetite is the predominant mineral with secondary hematite being the second most abundant iron oxide mineral. In the investigated samples vanadium concentration in magnetite ranges from 0.12 to 0.32% V2O3 with higher concentrations in the southern part of the deposit. No such conclusions regarding spatial distribution could be done for titanium. Furthermore, the investigations indicated that alteration from primary magnetite to secondary hematite does not significantly affect the trace element chemistry of the minerals. Titanium in iron oxides occurs as either inclusions or lamellae of titanium oxide minerals. Vanadium in iron oxides occur as a substitution element and does not occur in stochiometric vanadium minerals. It is considered unfeasible to lower the content of these deleterious elements by physical separation methods. / Leveäniemi är en järnoxid-apatitfyndighet (IOA) i Norrbotten som bryts av LKAB. Fyndigheten har en delvis mer komplex mineralogi än de närliggande och mer kända IOA-fyndigheterna Kiirunavaara och Malmberget. Leveäniemifyndigheten innehåller jämförelsevis mer malm innehållande både magnetit och hematit men även maghemit samt med något annorlunda spårämneskemi i järnoxidmineralen. Hematit anses inte i nuläget vara ett värdemineral i Svappavaaras malmförädling och i magnetitekoncentratet anses titan och vanadin utgöra straffelement. Malmprov togs från utvalda borrkärnor och från dessa tillverkades polerade tunnslip som undersöktes med optisk mikroskopering, EPMA och FE-SEM-EDS. Undersökningarna var fokuserade på järnoxidernas mineralogi och mineralkemi med speciellt fokus på titan och vanadin då grundämnena anses vara skadliga i efterföljande masugns- eller direktreduktionsprocesser. Undersökningarna visade att magnetit är det dominerade mineralet med sekundär hematit som det näst vanligaste förekommande järnoxidsmineralet. I de undersökta proven varierade vanadinhalten från 0,12% till 0,32% V2O3 med högre halter i fyndigheten södra delar. Inga liknande slutsatser angående rumsliga fördelningen av titan kunde göras. Vidare så indikerade undersökningarna att omvandling från primär magnetit till sekundär hematit inte nämnvärt påverkar spårämneskemin i mineralen. Titan i järnoxider förekommer antingen som inneslutning eller lameller av titanoxidsmineral. Vanadin i järnoxider förekommer som ett substitutionselement och förekommer inte som stökiometriska vanadinmineral. Det anses inte vara tekniskt eller ekonomiskt möjligt att sänka halterna av dessa skadliga grundämnen med hjälp av fysiska separationsmetoder.